IsomorphicLabs says AI can reverse drug discovery’s Eroom’s Law
AllThingsApx · x · 2026-07-24
IsomorphicLabs says it is using AI to reshape drug design, highlighting the contrast between Moore’s Law for cheaper compute and Eroom’s Law for increasingly expensive drug discovery.
In the ICML talk clip it frames the goal as faster discovery timelines and getting potential treatments to patients sooner.
More from Companies & People
- Fmr. OpenAI Design Head Ian Silber, Who Led ChatGPT and Codex, to Speak at SPC — soleio · 2026-10-26
- Silicon Valley breakdown: five Stanford-area giants worth ~$18T — FinanceYF5 · 2026-10-26
- User suspects X's bundled Grok subscription boosted tweet reach amid algorithm change rumors — talkaboutdesign · 2026-10-26
- "RIP Claude + Chrome": developer flags the end of Anthropic's browser integration — damienghader · 2026-10-26
- a16z podcast: Diode pairs AI PCB design with Brooklyn factory to revive US hardware manufacturing — MattPerault · 2026-10-26
- Vercel Ships 12 New Products at Its 2026 Conference as It Races Rivals for the Agent Entry Point — FinanceYF5 · 2026-10-26